Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Dingli

Showing results (151-160 of 471) with videos related to

Pageof 48
Sort By:
Blood|June 16, 2011
Efficacy of retreatment with immunomodulatory drugs (IMiDs) in patients receiving IMiDs for initial therapy of newly diagnosed multiple myelomaSumit Madan, Martha Q Lacy, Angela Dispenzieri, et al.
Haematologica|December 7, 2005
Combination therapy with thalidomide and dexamethasone in patients with newly diagnosed multiple myeloma not undergoing upfront autologous stem cell transplantation: a phase II trialDavid Dingli, S Vincent Rajkumar, Grzegorz S Nowakowski, et al.
Kidney International Reports|August 13, 2021
Epstein Barr Virus-Negative Lymphoplasmacytic Proliferation Limited to the Renal Allograft: A Unique Presentation of a Rare DiseaseMatthew R D'Costa, Rebecca L King, Mariam P Alexander, et al.
Haematologica|May 6, 2017
Serial measurements of circulating plasma cells before and after induction therapy have an independent prognostic impact in patients with multiple myeloma undergoing upfront autologous transplantationRajshekhar Chakraborty, Eli Muchtar, Shaji K Kumar, et al.
Leukemia & Lymphoma|October 29, 2020
Retroperitoneal involvement with light chain amyloidosis- case series and literature reviewIuliana Vaxman, Alissa Visram, Oren Pasvolsky, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 10, 2021
Efficacy of Daratumumab-Based Regimens for the Treatment of Plasma Cell LeukemiaRicardo D Parrondo, Muhamad Alhaj Moustafa, Craig Reeder, et al.
Transplantation and Cellular Therapy|April 10, 2021
Prognostic Implications of Rising Serum Monoclonal Protein and Free Light Chains after Autologous Stem Cell Transplantation in Patients with Multiple MyelomaHarsh Parmar, Abdullah S Al Saleh, Alissa Visram, et al.
NPJ Precision Oncology|May 20, 2023
ML-based sequential analysis to assist selection between VMP and RD for newly diagnosed multiple myelomaSung-Soo Park, Jong Cheol Lee, Ja Min Byun, et al.
British Journal of Haematology|November 29, 2024
Autologous stem cell transplantation for multiple myeloma patients whose myeloma-defining event was SLiMIuliana Vaxman, Shaji Kumar, Inbar Cohen, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|July 29, 2015
Autologous stem cell transplantation in immunoglobulin light chain amyloidosis with factor X deficiencyStefan Cordes, Morie A Gertz, Francis K Buadi, et al.
Pageof 48

Showing results (151-160 of 471) with videos related to

Sort By:
Pageof 48
Blood|June 16, 2011
Efficacy of retreatment with immunomodulatory drugs (IMiDs) in patients receiving IMiDs for initial therapy of newly diagnosed multiple myelomaSumit Madan, Martha Q Lacy, Angela Dispenzieri, et al.
Haematologica|December 7, 2005
Combination therapy with thalidomide and dexamethasone in patients with newly diagnosed multiple myeloma not undergoing upfront autologous stem cell transplantation: a phase II trialDavid Dingli, S Vincent Rajkumar, Grzegorz S Nowakowski, et al.
Kidney International Reports|August 13, 2021
Epstein Barr Virus-Negative Lymphoplasmacytic Proliferation Limited to the Renal Allograft: A Unique Presentation of a Rare DiseaseMatthew R D'Costa, Rebecca L King, Mariam P Alexander, et al.
Haematologica|May 6, 2017
Serial measurements of circulating plasma cells before and after induction therapy have an independent prognostic impact in patients with multiple myeloma undergoing upfront autologous transplantationRajshekhar Chakraborty, Eli Muchtar, Shaji K Kumar, et al.
Leukemia & Lymphoma|October 29, 2020
Retroperitoneal involvement with light chain amyloidosis- case series and literature reviewIuliana Vaxman, Alissa Visram, Oren Pasvolsky, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 10, 2021
Efficacy of Daratumumab-Based Regimens for the Treatment of Plasma Cell LeukemiaRicardo D Parrondo, Muhamad Alhaj Moustafa, Craig Reeder, et al.
Transplantation and Cellular Therapy|April 10, 2021
Prognostic Implications of Rising Serum Monoclonal Protein and Free Light Chains after Autologous Stem Cell Transplantation in Patients with Multiple MyelomaHarsh Parmar, Abdullah S Al Saleh, Alissa Visram, et al.
NPJ Precision Oncology|May 20, 2023
ML-based sequential analysis to assist selection between VMP and RD for newly diagnosed multiple myelomaSung-Soo Park, Jong Cheol Lee, Ja Min Byun, et al.
British Journal of Haematology|November 29, 2024
Autologous stem cell transplantation for multiple myeloma patients whose myeloma-defining event was SLiMIuliana Vaxman, Shaji Kumar, Inbar Cohen, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|July 29, 2015
Autologous stem cell transplantation in immunoglobulin light chain amyloidosis with factor X deficiencyStefan Cordes, Morie A Gertz, Francis K Buadi, et al.
Pageof 48